Investing in Global Innovation Mar 05, 2012 Vibhor Rastogi Investment Director, Intel Capital

FINANCIAL Intel Capital Mission Enhance Intel’s Strategic Objectives By Making and Managing Financially Attractive Investments STRATEGIC A Stage Agnostic and Long-Term Investor

Investing In a World of Possibilities Enterprise and Cloud Mobility Software and Services IntelligentSystems Ultrabooks Tablets Smart Phones AppUp Center™ Cloud Computing & Security Visual Computing & Open Source Servers, Networking & Storage Manageability & Virtualization Data Centers & Cloud Services Digital Signage Connected Car & IVI Home Energy Management Digital Media & Entertainment Consumer Internet ManufacturingMemory CleantechGreentech Content Delivery/Services Gaming & Education Advertising e-Commerce Social Media & Mobile Web Enabling Platforms Grid Infrastructure Smart Commercial Buildings Microgrids & Communities Semiconductor Process EDA Tools & IP Non-Volatile Memory

Intel Capital’s Investment Criteria When making investments, we look for: ● Innovative technology and usage models ● Strategic interest to Intel ● Strong management teams ● Addresses rapidly growing and sizable markets ● Exit opportunity

6 IPOs 28 Acquisitions 6 IPOs 28 Acquisitions 51% Outside N. America 74 International Investments 51% Outside N. America 74 International Investments Intel Capital Investments 2011 Historical 158 New Deals $526M 158 New Deals $526M 194 IPOs 289 Acquisitions 194 IPOs 289 Acquisitions 36% Outside N. America 51 Countries 36% Outside N. America 51 Countries 1,212 Deals $10.4 Billion 1,212 Deals $10.4 Billion

2011 Investments

*Other marks and brands are property of their respective owners 2011 Intel Capital Exits 34 Portfolio Company Exits: 28 M&A and 6 IPOs USA China India Netherlands Japan France UK Israel China: NASDAQ China: NYSE China: GTSM Poland: GPW Taiwan: GTSM Taiwan: TSEC

Intel Offices Intel Capital Invested Intel Capital Offices in 26 countries Investments in 51 Countries Intel Capital Global Presence Invested $10.4+ Billion in 51 Countries

Successful Investments *Other marks and brands are property of their respective owners Helping to Support Successful Global Businesses Since 1991

Global Investment Syndicate *Other marks and brands are property of their respective owners Worldwide Co-investors Providing Ready Access to Growth Capital, Global Market Reach, Board Members and Advisors

Intel Capital Technology Days Delivering value for customers and portfolio companies *Other marks and brands are property of their respective owners Ver. Dec 2011 Shortcuts the Corporate Technology Evaluation Cycle by Directly Connecting Portfolio Companies with Industry Executives

Intel Capital’s Unique Advantages ● One of the largest technology venture capital organizations worldwide ● Invests at all stages in private and public companies ● Leads investment rounds, takes larger stakes, actively participates on boards ● Speed and agility to make quick decisions ● Global brand recognition ● Committed to portfolio company success

Provider and Payer Technologies Pay for Quality vs. Pay for Volume driving adoption of risk based entities such as ACOs Cloud based Ambulatory and Hospital EMRs lowering cost of adoption of clinical technologies and digitizing the HC ecosystem Big data for Clinical decision support an interesting new trend Payers trying to become more consumer focused in anticipation of rollout of HC reform in 2014 Source: Oppenheimer, Frost and Sullivan, CMS, Morgan Keegan Representative Portfolio

Remote Patient management Aging populations: 65+ expected to reach 53M by 2020 and 80M by 2050 in the US. This long term demographic trend a key driver for the remote patient monitoring market In place aging – There is greater desire on part of individuals and families to age in place. Remote patient management provides this flexibility Treatment of Costly diseases - Chronic heart failure (CHF) one of the most common causes of hospitalization for elderly Americans, and is also one of the nation’s most costly conditions to treat. Remote patient management effective in preventive treatment of patients Representative Portfolio Source: ABI Research

Consumer and Mobile Health Smartphone adoption Hundreds of million smart phones have the potential to be used for sensing and transmitting HC data Mobile PHR adoption accelerated by EHR adoption and potential for integration via standard data interfaces Increasing consumerism Twice as many Gen-X and Gen-Y consumers want to access and maintain their PHRs using a mobile device than do Baby Boomers and Seniors 50% of consumers in a recent study want a personal monitoring device to alert and guide them to make improvements in their health or treat a condition Representative Portfolio Source: PWC

Bioinformatics and Genomics Key Focus areas Genomics Proteomics Bioinformatics and bioanalytic portals Molecular modeling Computational chemistry Representative Portfolio Source: IDC

Investing in Global Innovation